NCT07176416Recruiting

Effective Phaco Time and Endothelial Cell Loss When Using Veritas

Aloha Vision Consultants

Start Date

10/3/2025

Completion Date

10/1/2026

Summary

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Adult patients undergoing age-related cataract surgery. * Planned use of the Catalys Precision Laser System. * Planned implantation of TECNIS intraocular lenses (IOLs). Exclusion Criteria: • Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).

Interventions

DEVICE

Veritas Vision System

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cataract

Locations

Aloha Vision Consultants

‘Aiea, Hawaii 96701

United States